本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 安徽华尔泰化工股份有限公司（以下简称"公司"）第六届监事会第四次会 议于 2025 年 4 月 16 日在公司会议室以现场会议的方式召开。会议通知已于 2025 年 4 月 3 日以电话、邮件方式送达。本次会议应出席监事 3 名，实际出席监事 3 名。会议由监事会主席吴澳洲先生主持。本次会议的出席人数、召集、召开程序 和议事内容均符合《中华人民共和国公司法》和《安徽华尔泰化工股份有限公司 章程》（以下简称"《公司章程》"）的有关规定。 二、监事会会议审议情况 会议经审议做出了如下决议： （一）审议通过《关于<2024 年度监事会工作报告>的议案》 证券代码：001217 证券简称：华尔泰 公告编号：2025-004 安徽华尔泰化工股份有限公司 关于第六届监事会第四次会议决议公告 2024 年度，公司监事会严格按照《公司法》《公司章程》《监事会议事规 则》等相关法律法规及规范性文件的要求，切实维护公司和广大股东权益，认真 履行了监督职责。 具体内容详见公司同日刊登在巨潮资讯网（http:// ...

安徽华尔泰化工股份有限公司 关于第六届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 证券代码：001217 证券简称：华尔泰 公告编号：2025-003 安徽华尔泰化工股份有限公司（以下简称"公司"）第六届董事会第四次会议 于 2025 年 4 月 16 日（星期三）在公司会议室以现场结合通讯的方式召开，董事 陈有仁先生、乔治武先生、娄耀辉先生、胡海川先生以通讯表决方式出席会议。 会议通知已于 2025 年 4 月 3 日以电话、邮件方式送达。本次会议应出席董事 9 名，实际出席董事 9 名。会议由董事长吴炜先生主持，公司全体监事、高级管理 人员列席了会议。本次会议的出席人数、召集、召开程序和议事内容均符合《中 华人民共和国公司法》和《安徽华尔泰化工股份有限公司章程》（以下简称"《公 司章程》"）的有关规定。 二、董事会会议审议情况 会议经审议做出了如下决议： （一） 审议通过《关于<2024 年度董事会工作报告>的议案》 董事会严格按照相关法律、行政法规和中国证监会的规定，编制了《2024 年度董事会工作报 ...

关于 2024 年度利润分配预案的公告 证券代码：001217 证券简称：华尔泰 公告编号：2025-012 安徽华尔泰化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、审议程序 安徽华尔泰化工股份有限公司（以下简称"公司"）于 2025 年 4 月 16 日召 开了第六届董事会第四会议和第六届监事会第四次会议，审议通过了《关于 2024 年度利润分配预案的议案》，该议案尚需提交公司 2024 年年度股东大会审议。 二、利润分配预案基本情况 根据容诚会计师事务所（特殊普通合伙）出具的标准无保留意见的审计报告， 公司 2024 年度合并报表归属于母公司股东的净利润为 87,742,684.12 元，2024 年末可供分配的利润为 912,531,390.67 元。 公司 2024 年度母公司实现净利润 87,950,258.30 元，公司根据《公司法》和 《公司章程》等相关规定按 2024 年度母公司净利润的 10%提取法定盈余公积金 8,795,025.83 元，加上上年结转的未分配利润 868,512,572.91 元，减去 2023 年 ...

Revenue and Profitability - The company's revenue for Q1 2025 was CNY 470,703,009.57, representing a 19.25% increase compared to CNY 394,707,255.02 in the same period last year[5] - Net profit attributable to shareholders decreased by 48.90% to CNY 17,031,941.87 from CNY 33,329,636.28 year-on-year[5] - Basic and diluted earnings per share both dropped by 50.00% to CNY 0.05 from CNY 0.10[5] - Total operating revenue for the current period reached ¥470,703,009.57, an increase of 19.2% compared to ¥394,707,255.02 in the previous period[17] - Net profit for the current period was ¥17,031,941.87, a decrease of 48.9% from ¥33,329,636.28 in the previous period[18] - Earnings per share (EPS) for the current period was ¥0.05, down from ¥0.10 in the previous period[18] Cash Flow and Investments - The net cash flow from operating activities was negative at CNY -119,955,149.82, a decline of 227.02% compared to CNY -36,681,164.13 in the previous year[5] - Operating cash flow for the current period was -119,955,149.82 CNY, a decline from -36,681,164.13 CNY in the previous period, indicating a worsening cash flow situation[19] - Total cash inflow from investment activities was 112,755,028.03 CNY, compared to 81,689,387.05 CNY in the previous period, showing a significant increase of approximately 38%[19] - Cash outflow from investment activities totaled 175,154,540.03 CNY, up from 123,985,474.21 CNY, resulting in a net cash flow from investment activities of -62,399,512.00 CNY, worsening from -42,296,087.16 CNY[19] - Cash inflow from financing activities was 168,000,000.00 CNY, an increase from 80,000,000.00 CNY in the previous period, reflecting a growth of 110%[20] - Net cash flow from financing activities improved to 137,299,833.33 CNY, compared to 79,429,782.33 CNY previously, indicating a positive trend[20] - Cash inflow from sales of goods and services was 398,114,029.45 CNY, down from 452,333,023.23 CNY, indicating a decrease of about 12%[19] - Total cash outflow from operating activities was 519,775,771.95 CNY, compared to 490,642,787.95 CNY in the previous period, reflecting an increase of approximately 6%[19] - The ending cash and cash equivalents balance decreased to 99,525,391.18 CNY from 224,797,981.10 CNY, representing a decline of approximately 56%[20] Assets and Liabilities - Total assets increased by 1.14% to CNY 3,612,128,866.66 from CNY 3,571,405,137.25 at the end of the previous year[5] - Total liabilities rose to ¥1,335,866,549.76, up from ¥1,313,024,647.37 in the prior period[16] - Total equity attributable to shareholders increased to ¥2,276,262,316.90, compared to ¥2,258,380,489.88 in the previous period[16] - Total current assets increased to CNY 1,000,712,193.72 from CNY 898,506,117.12, reflecting a growth of approximately 11.1%[14] - Cash and cash equivalents decreased to CNY 195,355,311.11 from CNY 229,756,286.42, a decline of about 14.9%[14] - The company’s fixed assets increased significantly to CNY 1,943,557,259.56 from CNY 847,256,014.48, indicating a growth of approximately 129%[14] Income and Expenses - Total operating costs amounted to ¥455,735,069.44, up 26% from ¥361,733,662.14 in the prior period[17] - Research and development expenses were ¥12,617,953.66, an increase of 16.6% from ¥10,820,632.11 in the previous period[17] - The company reported a financial expense of ¥141,247.49, a significant improvement from a financial income of -¥684,287.18 in the previous period[17] - Deferred income tax liabilities increased to ¥27,950,296.69 from ¥25,867,857.10 in the previous period[16] Other Key Developments - The company reported a significant increase in trading financial assets, which rose by 109.55% to CNY 130,285,600.00 due to increased structured deposits[10] - Accounts receivable increased by 301.05% to CNY 1,036,500.00, influenced by the credit rating of bank acceptance bills[10] - Investment income surged by 3,499.01% to CNY 4,794,500.00, primarily due to increased returns from financial products[10] - The company experienced a 40.68% increase in other income, totaling CNY 4,665,200.00, attributed to deferred income growth[10] - The company completed the energy-saving and environmental upgrade project for synthetic ammonia production, entering the trial production phase as planned[12] - The company plans to continue its investment in R&D, which has contributed to increased expenses and depreciation of fixed assets[7] - The company plans to continuously optimize production processes and equipment to achieve full production capacity[12] - The company has not yet audited the first quarter report, which may affect the reliability of the financial data presented[21]

Financial Performance - The company's operating revenue for 2024 was CNY 1,641,061,339.78, a decrease of 8.42% compared to CNY 1,791,934,857.07 in 2023[20]. - The net profit attributable to shareholders for 2024 was CNY 87,742,684.12, down 44.56% from CNY 158,276,025.09 in the previous year[20]. - The net profit after deducting non-recurring gains and losses was CNY 78,779,358.67, a decline of 46.16% from CNY 146,311,474.97 in 2023[20]. - Basic earnings per share for 2024 were CNY 0.26, a decrease of 45.83% from CNY 0.48 in the previous year[20]. - The weighted average return on equity for 2024 was 3.95%, down from 7.42% in 2023[20]. - The company reported a significant decline in revenue from trading customers, which fell by 20.89% to ¥361,985,873.49, compared to ¥457,584,453.91 in 2023[57]. - The total revenue from the fine chemicals segment was CNY 397,130,572.82, with a year-on-year decrease of 5.81%[59]. - The total operating revenue for 2024 was ¥1,641,061,339.78, representing a decrease of 8.42% compared to ¥1,791,934,857.07 in 2023[56]. Cash Flow and Investments - The net cash flow from operating activities surged to CNY 433,848,636.45, an increase of 5,843.04% compared to CNY 7,300,112.05 in 2023[20]. - The total cash inflow from operating activities was approximately ¥1.97 billion, while cash outflow was about ¥1.54 billion, resulting in a net cash flow of approximately ¥433.85 million[74]. - The cash flow from investment activities saw a significant decline of 64.76%, primarily due to a reduction in the redemption of financial products[74]. - The net cash flow from financing activities decreased by 87.90%, attributed to pledged certificates of deposit[74]. - The company invested 4,959.79 million yuan in R&D, a decrease of 10.64% year-on-year[43]. Production and Capacity - The company has an annual production capacity of 400,000 tons of nitric acid, 600,000 tons of sulfuric acid, and 300,000 tons of hydrogen peroxide, leading the market in nitric acid capacity and market share[42]. - The company has a design capacity of 250,000 tons for concentrated nitric acid, with a utilization rate of 118%[33]. - The company has a total capacity of 600,000 tons for sulfuric acid, with a utilization rate of 88%[33]. - The company has a production capacity of 30,000 tons for hydrogen peroxide, with a utilization rate of 96%[33]. - The company has a total of 15,000 tons of in-construction capacity for concentrated nitric acid[33]. Research and Development - The company has applied for 71 patents, including 16 invention patents, enhancing its technological innovation capabilities[36]. - The R&D center has been operational, focusing on projects such as the quality distillation of sulfur trioxide and carbon removal from hydrogen peroxide products[52]. - The company invested 55.8281 million yuan in projects funded by raised funds, with a cumulative investment of 738.3561 million yuan[88]. - The company is focusing on technological innovation and talent cultivation to reduce costs and improve production technology levels[101]. Environmental and Safety Compliance - The company complies with national environmental protection laws and regulations, executing the strictest emission limits for pollutants such as particulate matter, sulfur dioxide, and nitrogen oxides[174]. - The company has obtained environmental impact assessment approvals for all current and new projects, including a 100,000-ton nitric acid project approved in January 2005 and a 150,000-ton nitric acid construction project approved in December 2011[174]. - The company is committed to resource utilization and has implemented a project for comprehensive utilization of "three wastes" with approval received in December 2018[174]. - The company has established a comprehensive safety and environmental responsibility system, enhancing management and assessment methods for environmental compliance[178]. Governance and Shareholder Engagement - The company has a clear cash dividend policy that allows for adequate expression of opinions and protection of minority shareholders' rights[164]. - The company is committed to maintaining transparency and effective communication with stakeholders during this transition period[132]. - The board of directors consists of nine members, including three independent directors, ensuring compliance with legal requirements[114]. - The company has outlined its commitment to shareholder engagement through regular meetings and updates[126]. Market Expansion and Strategic Initiatives - The company is actively expanding its overseas market presence and enhancing its environmental safety measures in response to stricter regulations[30]. - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products were not detailed in the call[131]. - The company is responding to the explosive growth in demand for wet chemicals in the domestic chip industry by accelerating the development of electronic chemicals[98]. - The company plans to enhance its digital marketing strategy, expecting a 40% increase in online sales[142]. Employee and Talent Management - The total number of employees at the end of the reporting period is 1,237, with 846 in production, 45 in sales, 260 in technical roles, 13 in finance, and 73 in administration[159]. - The company emphasizes a performance-oriented compensation system, integrating basic salary guarantees with incentive pay to foster talent development[160]. - The training plan includes various programs aimed at enhancing employee skills and leadership capabilities, ensuring continuous professional growth[161]. - Research and development (R&D) personnel increased by 6.86% from 204 to 218, with the proportion of R&D personnel in the company rising from 16.00% to 17.62%[72].

华尔泰（001217）公告，2025年第一季度营业收入4.71亿元，同比增长19.25%。净利润1703.19万元， 同比下降48.90%。 ...

| | | | /Lが目/ 木つUUfBx 目田A 今年以来各阶段业绩及同类排名 | | | | --- | --- | --- | --- | --- | --- | | 阶段涨幅 | 李度涨幅 | 年度涨幅 | | | | | | 近1周 | | 近1月 | 近3月 | 新功能:"小天 | | 阶段涨幅 | | -6.46% | -6.94% | -3.05% | 型,智能问答 | | 同类平均6 | | -8.59% | -10.69% | -2.25% | 准、 专业的问 | | 沪深300 | | -5.09% | -6.52% | -2.46% | | | 跟踪标的2 | | -5.09% | -6.52% | -2.46% | | | 同类排名 3 | | | 1026 3636 976 3598 1991 3448 13 | | | | | | | | | 图片来源:天天基金网 2025/4/9 | 4月9日，华尔泰连续7个交易日下跌，区间累计跌幅-31.09%。安徽华尔泰化工股份有限公司是一家致力于基础化工、精细化工和化工新材料产品制造的现代 化、综合型化工企业,为化工制造、生物医药、金属冶 ...

证券代码：001217 证券简称：华尔泰 公告编号：2025-002 安徽华尔泰化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 安徽华尔泰化工股份有限公司（以下简称"公司"或"本公司"）（证券简 称：华尔泰，证券代码：001217）股票连续两个交易日内（2025 年 3 月 27 日、 所交易规则》的相关规定，属于股票交易异常波动情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动，公司采用电话和书面方式对公司控股股东和实 际控制人就相关事项进行了核实，有关情况说明如下： 情形； 三、不存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据深交所《股票上市规则》等有 关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等； 董事会也未获悉本公司有根据深交所《股票上市规则》等有关规定应予以披露而 未披露的、对本公司股票及其衍生品种交易价格产生较大影响的信息；公司前期 披露的信息不存在需要更正、补充之处。 四、风险提示 年 4 月 18 日披露，公司未向除为公司审计的会计师 ...

证券代码：001217 证券简称：华尔泰 公告编号：2025-002 安徽华尔泰化工股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 安徽华尔泰化工股份有限公司（以下简称"公司"或"本公司"）（证券简 称：华尔泰，证券代码：001217）股票连续两个交易日内（2025 年 3 月 27 日、 2025 年 3 月 28 日）日收盘价格涨幅偏离值累计达到 20%，根据《深圳证券交易 所交易规则》的相关规定，属于股票交易异常波动情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动，公司采用电话和书面方式对公司控股股东和实 际控制人就相关事项进行了核实，有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处； 本公司董事会确认，本公司目前没有任何根据深交所《股票上市规则》等有 关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等； 董事会也未获悉本公司有根据深交所《股票上市规则》等有关规定应予以披露而 未披露的、对本公司股票及其衍生品种交易价格产生较大影响的信息 ...